Genetic Variants That Associate with Cirrhosis Have Pleiotropic Effects on Human Traits

Overview

Journal Liver Int

Specialty Gastroenterology

Date 2019 Dec 10

PMID 31815349

Citations 24

Authors

Vincent L Chen

Yanhua Chen

Xiaomeng Du

Samuel K Handelman

Elizabeth K Speliotes

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Cirrhosis is characterized by extensive fibrosis of the liver and is a major cause of liver-related mortality. Cirrhosis is partially heritable but genetic contributions to cirrhosis have not been systemically explored. Here, we carry out association analyses with cirrhosis in two large biobanks and determine the effects of cirrhosis associated variants on multiple human disease/traits.

Methods: We carried out a genome-wide association analysis of cirrhosis as a diagnosis in UK BioBank (UKBB; 1088 cases vs. 407 873 controls) and then tested top-associating loci for replication with cirrhosis in a hospital-based cohort from the Michigan Genomics Initiative (MGI; 875 cases of cirrhosis vs. 30 346 controls). For replicating variants or variants previously associated with cirrhosis that also affected cirrhosis in UKBB or MGI, we determined single nucleotide polymorphism effects on all other diagnoses in UKBB (PheWAS), common metabolic traits/diseases and serum/plasma metabolites.

Results: Unbiased genome-wide association study identified variants in/near PNPLA3 and HFE, and candidate variant analysis identified variants in/near TM6SF2, MBOAT7, SERPINA1, HSD17B13, STAT4 and IFNL4 that reproducibly affected cirrhosis. Most affected liver enzyme concentrations and/or aspartate transaminase-to-platelet ratio index. PheWAS, metabolic trait and serum/plasma metabolite association analyses revealed effects of these variants on lipid, inflammatory and other processes including new effects on many human diseases and traits.

Conclusions: We identified eight loci that reproducibly associate with population-based cirrhosis and define their diverse effects on human diseases and traits.

Citing Articles

Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application.

Chen V, Brady G Hepatol Commun. 2025; 9(1.

PMID: 39774697 PMC: 11717516. DOI: 10.1097/HC9.0000000000000618.

Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort.

Chen V, Du X, Oliveri A, Chen Y, Kuppa A, Halligan B J Hepatol. 2024; 81(3):379-388.

PMID: 38582304 PMC: 11347099. DOI: 10.1016/j.jhep.2024.03.045.

Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.

Mahmoudi S, Tarzemani S, Aghajanzadeh T, Kasravi M, Hatami B, Zali M Eur J Med Res. 2024; 29(1):190.

PMID: 38504356 PMC: 10953212. DOI: 10.1186/s40001-024-01708-8.

Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease.

Suresh D, Li A, Miller M, Wijarnpreecha K, Chen V Liver Int. 2023; 44(2):389-398.

PMID: 37971775 PMC: 10872664. DOI: 10.1111/liv.15787.

Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.

Chen Y, Du X, Kuppa A, Feitosa M, Bielak L, OConnell J Nat Genet. 2023; 55(10):1640-1650.

PMID: 37709864 PMC: 10918428. DOI: 10.1038/s41588-023-01497-6.

References

Maguire L, Handelman S, Du X, Chen Y, Pers T, Speliotes E . Genome-wide association analyses identify 39 new susceptibility loci for diverticular disease. Nat Genet. 2018; 50(10):1359-1365. PMC: 6168378. DOI: 10.1038/s41588-018-0203-z. View

Stickel F, Buch S, Zoller H, Hultcrantz R, Gallati S, Osterreicher C . Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis. Hum Mol Genet. 2014; 23(14):3883-90. DOI: 10.1093/hmg/ddu076. View

M Greene C, Marciniak S, Teckman J, Ferrarotti I, Brantly M, Lomas D . α1-Antitrypsin deficiency. Nat Rev Dis Primers. 2016; 2:16051. DOI: 10.1038/nrdp.2016.51. View

Hamesch K, Mandorfer M, Pereira V, Moeller L, Pons M, Dolman G . Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation. Gastroenterology. 2019; 157(3):705-719.e18. DOI: 10.1053/j.gastro.2019.05.013. View

Kim R, Nguyen P, Bettencourt R, Dulai P, Haufe W, Hooker J . Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study. Aliment Pharmacol Ther. 2016; 44(3):287-99. DOI: 10.1111/apt.13691. View

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J . UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015; 12(3):e1001779. PMC: 4380465. DOI: 10.1371/journal.pmed.1001779. View

Rueger S, Bochud P, Dufour J, Mullhaupt B, Semela D, Heim M . Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut. 2014; 64(10):1605-15. DOI: 10.1136/gutjnl-2014-306997. View

Kettunen J, Demirkan A, Wurtz P, Draisma H, Haller T, Rawal R . Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun. 2016; 7:11122. PMC: 4814583. DOI: 10.1038/ncomms11122. View

Dey R, Schmidt E, Abecasis G, Lee S . A Fast and Accurate Algorithm to Test for Binary Phenotypes and Its Application to PheWAS. Am J Hum Genet. 2017; 101(1):37-49. PMC: 5501775. DOI: 10.1016/j.ajhg.2017.05.014. View

10.

Lu Y, Day F, Gustafsson S, Buchkovich M, Na J, Bataille V . New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat Commun. 2016; 7:10495. PMC: 4740398. DOI: 10.1038/ncomms10495. View

11.

Tanash H, Piitulainen E . Liver disease in adults with severe alpha-1-antitrypsin deficiency. J Gastroenterol. 2019; 54(6):541-548. PMC: 6536463. DOI: 10.1007/s00535-019-01548-y. View

12.

Dai Z, Liu X, Wang M, Guo Y, Zhu W, Li X . IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study. Oncotarget. 2017; 8(46):81350-81360. PMC: 5655289. DOI: 10.18632/oncotarget.18531. View

13.

Zhou W, Zhang Q, Qiao L . Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014; 20(23):7312-24. PMC: 4064077. DOI: 10.3748/wjg.v20.i23.7312. View

14.

Canela-Xandri O, Rawlik K, Tenesa A . An atlas of genetic associations in UK Biobank. Nat Genet. 2018; 50(11):1593-1599. PMC: 6707814. DOI: 10.1038/s41588-018-0248-z. View

15.

Huang L, Mo Z, Li S, Qin X . The association between PIN1 genetic polymorphisms and the risk of chronic hepatitis B and hepatitis B virus-related liver cirrhosis: A case-control study. Medicine (Baltimore). 2018; 97(35):e12123. PMC: 6392626. DOI: 10.1097/MD.0000000000012123. View

16.

Kilpelainen T, Martin Carli J, Skowronski A, Sun Q, Kriebel J, Feitosa M . Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat Commun. 2016; 7:10494. PMC: 4740377. DOI: 10.1038/ncomms10494. View

17.

Song Q, He X, Yang H, Li J, Chen M, Wang M . Association of a TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population. Viral Immunol. 2012; 25(1):73-8. DOI: 10.1089/vim.2011.0053. View

18.

Shungin D, Winkler T, Croteau-Chonka D, Ferreira T, Locke A, Magi R . New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015; 518(7538):187-196. PMC: 4338562. DOI: 10.1038/nature14132. View

19.

Morris A, Voight B, Teslovich T, Ferreira T, V Segre A, Steinthorsdottir V . Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44(9):981-90. PMC: 3442244. DOI: 10.1038/ng.2383. View

20.

Speliotes E, Yerges-Armstrong L, Wu J, Hernaez R, Kim L, Palmer C . Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011; 7(3):e1001324. PMC: 3053321. DOI: 10.1371/journal.pgen.1001324. View